GHRP-2 Peptide research-grade
GHRP-2 Peptide
$27.00 $36.00Price range: $27.00 through $36.00 Select options

GHRP-2 Peptide

Price range: $27.00 through $36.00

Laboratory-grade GHRP-2 Peptide is a synthetic growth hormone releasing hexapeptide (pralmorelin) used in ghrelin-mimetic research. Research buyers select this listing for pre-clinical work on GHS-R1a signaling and pituitary secretagogue assays—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

GHRP-2 Peptide research-grade

Overview

Laboratory-grade GHRP-2 Peptide presents as a synthetic growth hormone releasing hexapeptide (pralmorelin) used in ghrelin-mimetic research. Nationwide lists this SKU for controlled research programs focused on GHS-R1a signaling and pituitary secretagogue assays—not for clinical, veterinary, or consumer use.

Research buyers specify GHRP-2 Peptide when protocols require a characterized input for GHS-R1a signaling and pituitary secretagogue assays. Typical deployments include cell-based or cell-free assays, method development plates, and pathway-mapping models executed under institutional laboratory SOPs.

Procurement and receiving teams rely on this listing for vial identity, lot continuity, and research-only labeling. Keep GHRP-2 Peptide inside validated reconstitution and custody procedures from intake through disposal of residual solutions.

Research Context for GHRP-2 Peptide

Work involving GHRP-2 Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of GHRP-2 Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source GHRP-2 Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with GHRP-2 Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using GHRP-2 Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of GHRP-2 Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 47 PubMed records. Displaying 10 per page.

  1. Author et al. (2004). Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN,… [PMID: 15230633]

    Laboratory literature summary: Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Roh SG et al. (2002). Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat… [PMID: 11956179]

    Laboratory literature summary: Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Thomas A et al. (2010). Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional… [PMID: 20878896]

    Laboratory literature summary: Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Semenistaya E et al. (2015). Determination of growth hormone releasing peptides metabolites in research subjects… [PMID: 25869809]

    Laboratory literature summary: Determination of growth hormone releasing peptides metabolites in research subjects urine after nasal administration of GHRP-1, GHRP-2,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Cox HD et al. (2015). Detection of GHRP-2 and GHRP-6 in urine samples from athletes [PMID: 25809000]

    Laboratory literature summary: Detection of GHRP-2 and GHRP-6 in urine samples from athletes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Laferrère B et al. (2005). Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in… [PMID: 15699539]

    Laboratory literature summary: Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Bowers CY et al. (1996). GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to… [PMID: 8887169]

    Laboratory literature summary: GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Chen C et al. (1998). Growth hormone-releasing peptide-2 (GHRP-2) does not act via the research subjects… [PMID: 9798733]

    Laboratory literature summary: Growth hormone-releasing peptide-2 (GHRP-2) does not act via the research subjects growth hormone-releasing factor receptor in GC cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Zeng P et al. (2014). Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal… [PMID: 24607724]

    Laboratory literature summary: Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Popławska M et al. (2019). Identification of a novel growth hormone releasing peptide (a glycine analogue of… [PMID: 30051972]

    Laboratory literature summary: Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized parenteral-route administration vial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Kinoshita Y et al. (2013). The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the… [PMID: 23079545]

    Laboratory literature summary: The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the analytical assessment of adult GH deficiency in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Granado M et al. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2… [PMID: 15507538]

    Laboratory literature summary: Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Doi N et al. (2004). Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing… [PMID: 15646370]

    Laboratory literature summary: Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Sheriff S et al. (2009). Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx… [PMID: 19577604]

    Laboratory literature summary: Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Hu R et al. (2016). Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic… [PMID: 26894743]

    Laboratory literature summary: Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Ohara E et al. (2017). Laboratory research record on GHRP-2 [PMID: 28623445]

    PubMed laboratory record discussing GHRP-2 in a research context. Review the full methods and limitations on PubMed; research use only.

  17. Granado M et al. (2005). Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3… [PMID: 16030067]

    Laboratory literature summary: Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Van den Berghe G et al. (2002). The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to… [PMID: 12030918]

    Laboratory literature summary: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to research subjects with prolonged critical illness evokes…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Chen C et al. (1995). Effects of growth hormone-releasing peptide-2 (GHRP-2) on membrane Ca2+ permeability… [PMID: 7606243]

    Laboratory literature summary: Effects of growth hormone-releasing peptide-2 (GHRP-2) on membrane Ca2+ permeability in cultured ovine somatotrophs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Wideman L et al. (2000). Synergy of L-arginine and GHRP-2 stimulation of growth hormone in research subjects… [PMID: 11004017]

    Laboratory literature summary: Synergy of L-arginine and GHRP-2 stimulation of growth hormone in research subjects and research subjects: modulation by exercise. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Arvat E et al. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH,… [PMID: 9285939]

    Laboratory literature summary: Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Arvat E et al. (1999). Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of… [PMID: 10195374]

    Laboratory literature summary: Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Wu D et al. (1994). The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary… [PMID: 8169551]

    Laboratory literature summary: The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Furuta S et al. (2004). General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide [PMID: 15646371]

    Laboratory literature summary: General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Wu D et al. (1996). The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine… [PMID: 8699133]

    Laboratory literature summary: The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Kimura T et al. (2010). Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth… [PMID: 20431231]

    Laboratory literature summary: Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2),…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Balasubramaniam A et al. (2009). GHRP-2 attenuates burn-induced dysfunctions in rodents [PMID: 19400318]

    Laboratory literature summary: GHRP-2 attenuates burn-induced dysfunctions in rodents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Reverter-Branchat G et al. (2021). On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse [PMID: 33197153]

    Laboratory literature summary: On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Okano M et al. (2010). Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite… [PMID: 20552695]

    Laboratory literature summary: Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in research subjects urine by liquid…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Cheng J et al. (1997). Growth hormone releasing peptides: a comparison of the growth hormone releasing… [PMID: 9096259]

    Laboratory literature summary: Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Liu Q et al. (1999). Laboratory research record on GHRP-2 [PMID: 12938517]

    PubMed laboratory record discussing GHRP-2 in a research context. Review the full methods and limitations on PubMed; research use only.

  32. Yamamoto D et al. (2008). GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the… [PMID: 18191156]

    Laboratory literature summary: GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Okano M et al. (2010). Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2)… [PMID: 21249726]

    Laboratory literature summary: Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Lee HG et al. (2005). Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma… [PMID: 15713362]

    Laboratory literature summary: Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma IGF-1 and IGFBPs in Holstein steers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Mericq V et al. (2003). Changes in feeding-behavior endpoints and body weight in response to long-term oral administration of… [PMID: 14513874]

    Laboratory literature summary: Changes in feeding-behavior endpoints and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Veldhuis JD et al. (2009). Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in research… [PMID: 19351731]

    Laboratory literature summary: Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in research subjects: evaluation using a GnRH…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Phung LT et al. (2000). The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth… [PMID: 10793268]

    Laboratory literature summary: The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. Hirotani C et al. (2005). ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF [PMID: 15645295]

    Laboratory literature summary: ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Chen C et al. (1998). Effect of growth hormone-releasing peptide-2 (GHRP-2) and GH-releasing hormone (GHRH)… [PMID: 9688350]

    Laboratory literature summary: Effect of growth hormone-releasing peptide-2 (GHRP-2) and GH-releasing hormone (GHRH) on the the cAMP levels and GH release from…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Roh SG et al. (1997). Effects of muscarinic and adrenergic blockade on growth hormone secretion induced by… [PMID: 9622303]

    Laboratory literature summary: Effects of muscarinic and adrenergic blockade on growth hormone secretion induced by growth hormone-releasing peptide-2 (GHRP-2) in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Roh SG et al. (2006). Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in… [PMID: 17185792]

    Laboratory literature summary: Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro investigation of ovine pituitary cells with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Roh SG et al. (1996). Characteristics of growth hormone secretion responsiveness to growth hormone-releasing… [PMID: 8886623]

    Laboratory literature summary: Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Yan M et al. (2004). Effect of GHRH and GHRP-2 investigation in vitro on GH secretion and levels of GH,… [PMID: 14763922]

    Laboratory literature summary: Effect of GHRH and GHRP-2 investigation in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Phung LT et al. (2001). Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by… [PMID: 11164330]

    Laboratory literature summary: Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Chen C (2002). The effect of two-day investigation of primary cultured ovine somatotropes with GHRP-2… [PMID: 12072399]

    Laboratory literature summary: The effect of two-day investigation of primary cultured ovine somatotropes with GHRP-2 on membrane voltage-gated K+ currents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Kamoi K et al. (2010). Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2… [PMID: 20953065]

    Laboratory literature summary: Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Gaudiano MC et al. (2014). Identification and quantification of the doping agent GHRP-2 in seized unlabelled… [PMID: 24446112]

    Laboratory literature summary: Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight.125 lbs
Dimensions9 × 7 × .5 in
Size: No selection

5 mg, 10 mg, 15 mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is GHRP-2 peptide?

GHRP-2 is a synthetic growth hormone-releasing peptide studied in research laboratories for its role in ghrelin receptor signaling and endocrine pathway activity.

What is GHRP-2 used for in research?

GHRP-2 is used in research laboratories to investigate peptide-receptor interactions, growth hormone signaling, and metabolic pathway mechanisms. It is not approved for human use.

Is GHRP-2 Peptide approved or intended for human use?

No. GHRP-2 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is GHRP-2 Peptide FDA-approved for medical or clinical use?

No. GHRP-2 is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is GHRP-2 supplied?

GHRP-2 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should GHRP-2 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for GHRP-2?

GHRP-2 is available in multiple vial sizes.

Is GHRP-2 Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is GHRP-2 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://nationwidepeptides.com/shipping-and-payments

How can I verify GHRP-2 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://nationwidepeptides.com/coa/